Therefore, the dependence of CBL0137 anti-tumor activity on FACT subunit expression was tested in vivo against a panel of patient-derived pancreatic cancer xenografts (PDX) with varied expression of FACT subunits (Table 1). Here, SUPT16H is linked to pancreatic neoplasm.